Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RST
726
DELISTED
ROSETTA STONE INC
RST
| $10.2M | 0.03% |
+692,500
| New | +$11.3M |
|
|
KEYN
727
DELISTED
KEYNOTE SYSTEMS INC
KEYN
| $10.2M | 0.03% |
+515,740
| New | +$6.76M |
|
728
Dominion Energy
D
$61.8B
| $10.2M | 0.03% |
+179,300
| New | +$10.5M |
|
|
EFII
729
DELISTED
Electronics for Imaging
EFII
| $10.1M | 0.03% |
+358,759
| New | +$9.61M |
|
|
CKEC
730
DELISTED
Carmike Cinemas Inc
CKEC
| $10.1M | 0.03% |
+523,700
| New | +$9.07M |
|
|
JNS
731
DELISTED
Janus Capital Group Inc
JNS
| $10.1M | 0.03% |
+1,190,500
| New | +$10.4M |
|
|
HPY
732
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
| $10.1M | 0.03% |
+271,900
| New | +$8.84M |
|
|
CKH
733
DELISTED
Seacor Holdings Inc.
CKH
| $10.1M | 0.03% |
+125,941
| New | +$9.27M |
|
|
CBM
734
DELISTED
Cambrex Corporation
CBM
| $10.1M | 0.03% |
+723,500
| New | +$9.46M |
|
735
Extreme Networks
EXTR
$3.92B
| $10.1M | 0.03% |
+2,935,561
| New | +$9.79M |
|
736
Jazz Pharmaceuticals
JAZZ
$16B
| $10.1M | 0.03% |
+146,800
| New | +$8.97M |
|
|
RSO
737
DELISTED
Resource Capital Corp.
RSO
| $10.1M | 0.03% |
+409,346
| New | +$10.5M |
|
738
Gilead Sciences
GILD
$162B
| $10.1M | 0.03% |
+196,248
| New | +$10.2M |
|
739
Archrock
AROC
$6.26B
| $10.1M | 0.03% |
+357,790
| New | +$9.84M |
|
|
ENOC
740
DELISTED
EnerNOC, Inc.
ENOC
| $10.1M | 0.03% |
+758,000
| New | +$11.8M |
|
741
Icon
ICLR
$13B
| $10M | 0.03% |
+283,160
| New | +$9.31M |
|
742
Reinsurance Group of America
RGA
$15.7B
| $10M | 0.03% |
+144,800
| New | +$9.16M |
|
743
National Beverage
FIZZ
$2.93B
| $10M | 0.03% |
+1,145,400
| New | +$8.95M |
|
744
Entravision Communication
EVC
$1.02B
| $9.98M | 0.03% |
+1,622,100
| New | +$7.21M |
|
745
SM Energy
SM
$7.26B
| $9.96M | 0.03% |
+166,100
| New | +$10.1M |
|
|
HMSY
746
DELISTED
HMS Holdings Corp.
HMSY
| $9.96M | 0.03% |
+427,512
| New | +$10.6M |
|
|
KZ
747
DELISTED
KongZhong Corporation
KZ
| $9.93M | 0.03% |
+1,527,500
| New | +$9.68M |
|
748
Amdocs
DOX
$5.64B
| $9.85M | 0.03% |
+265,500
| New | +$9.48M |
|
749
Ovintiv
OVV
$16.6B
| $9.8M | 0.03% |
+115,680
| New | +$10.7M |
|
|
WTSL
750
DELISTED
WET SEAL INC CL-A
WTSL
| $9.8M | 0.03% |
+2,075,580
| New | +$8.22M |
|
Similar funds
Renaissance Technologies's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.